Costo Efectividad del Tratamiento de Tumores Neuroendócrinos Pancreáticos Avanzados no Operables con Sunitinib en México Emilio Muciño Ortega, MSc, Alfredo Chi-Chan, MD, Gustavo Peniche-Otero, BEcon, Consuelo I. Gutiérrez-Colín, MD, Joaquín Herrera- Rojas, BEng, Rosa María Galindo-Suárez, MSc Value in Health Regional Issues Volume 1, Issue 2, Pages 150-155 (December 2012) DOI: 10.1016/j.vhri.2012.10.005 Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions
Figura 1 Estados de salud y transiciones posibles en el modelo de Markov. Value in Health Regional Issues 2012 1, 150-155DOI: (10.1016/j.vhri.2012.10.005) Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions
Figura 2 Diagrama de tornado para la RCEI en supervivencia global. Value in Health Regional Issues 2012 1, 150-155DOI: (10.1016/j.vhri.2012.10.005) Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions
Figura 3 Análisis de sensibilidad probabilístico para la supervivencia global. Value in Health Regional Issues 2012 1, 150-155DOI: (10.1016/j.vhri.2012.10.005) Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions
Figura 4 Curva de aceptabilidad para la supervivencia global. Value in Health Regional Issues 2012 1, 150-155DOI: (10.1016/j.vhri.2012.10.005) Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions